International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-5 doi: 10.5281/zenodo.8427430
Original Article
Bone Mineral Density and Body Composition Estimation Using Dexa Scan In Chronic Kindey Disease Patients
 ,
 ,
 ,
 ,
Published
Oct. 8, 2023
Abstract

Background: Chronic kidney disease (CKD) is known to have significant repercussions on bone mineral density (BMD) and body composition. We aimed to evaluate BMD and body composition alterations across different stages of CKD.

Methods: A hospital based Observational study was carried out in 120 patients in the Department of Medicine, Assam Medical College & Hospital, Dibrugarh for a period of one year from 1st July, 2021 to 30th June, 2022.  BMD at the femur neck and lumbar spine was evaluated using Z-scores. Body composition was assessed focusing on sarcopenia prevalence and body fat percentage across CKD stages.

Results: In our study, based on the Z-score at the femur neck, 45% of participants had osteopenia, with a slightly higher prevalence in females (23.33%) compared to males (21.67%). Osteoporosis was identified in 31.67% of the cases, with females (16.67%) again slightly outnumbering males (15%). About 23.33% of the cases had a normal Z-score, with males (15.83%) being more than females (7.50%).When assessing the Z-score at the lumbar spine, results showed a different distribution. Osteopenia was present in 43.34% of the cases, with females (24.17%) being more affected than males (19.17%). Osteoporosis was seen in 17.5% of the participants, with a nearly equal distribution between males (8.33%) and females (9.17%).From the total cohort of 120 patients, 54% were diagnosed with sarcopenia. Additionally, the mean fat mass varied slightly across stages 3, 4, and 5 of CKD but remained relatively consistent, with readings of 17.13±4.24, 16.71±3.49, and 16.95±4.83 respectively.

Conclusion: CKD exerts a substantial impact on bone health, with increasing prevalence of osteopenia and osteoporosis in advanced CKD stages. Additionally, a high prevalence of sarcopenia across CKD stages was observed, underscoring the necessity for comprehensive musculoskeletal management in CKD patients.

Recommended Articles
Loading Image...
Volume-4, Issue-5
Citations
1152 Views
279 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved